How many institutional investors hold CBIO?

3 tracked institutional investors disclosed a position in CBIO (CRESCENT BIOPHARMA INC.) in their most recent 13F filing.

Who is the largest institutional holder of CBIO?

Izzy Englander, Millennium Management, holds the largest disclosed position in CBIO, valued at $6M.

Where does this CBIO ownership data come from?

SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.

CBIO — CRESCENT BIOPHARMA INC.

Name: CRESCENT BIOPHARMA INC. (CBIO) — Institutional Ownership
Creator: InvestorLens
License: https://www.sec.gov/about/website-policies

Public company

For educational research only.InvestorLens analyzes public regulatory filings (SEC EDGAR, STOCK Act PTRs) that may be delayed by 45 days or more. Information shown is historical and is not financial, legal, or tax advice, nor a recommendation or solicitation to buy or sell any security. Always do your own research.

InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.

Sourced from SEC EDGAR public filings

About CRESCENT BIOPHARMA INC. (CBIO)

CRESCENT BIOPHARMA INC. (CBIO) appears in the most recent 13F filings of 3 tracked institutional investors. The largest disclosed position is held by Izzy Englander (Millennium Management), valued at $6M. Across recent filings, tracked investors recorded 2 new positions, 0 increased, 0 reduced, and 0 exited. All data sourced from SEC 13F filings.

Smart Money Consensus™

Based on recent institutional activity in CBIO

100

/100

Strong Institutional Accumulation

Added / Increased2

Reduced0

Exited0

BearishBullish

Crowded Trade Score™

How many top investors track CBIO

/100

Emerging Interest

3investors

A small number of top investors own this.

UndiscoveredCrowded

151015+

CBIO Ownership Composition

How CRESCENT BIOPHARMA INC. is held across tracked investor types, based on reported 13F positions.

Dominant Type

Other

53% of tracked value

Institutions

tracked investors

Total Reported

$11.8M

combined 13F value

Other53.1%
Hedge Funds46.9%

Other(2)

53.1%

Hedge Funds(1)

46.9%

Tracked investors reporting CBIO

Investor	Firm	Shares	Market value	% of portfolio	As of
Izzy Englander	Millennium Management	323.6K	$5.9M	0.00%	Mar 31, 2026
Steve Cohen	Point72 Asset Management	300K	$5.5M	0.01%	Mar 31, 2026
Ken Griffin	Citadel Advisors	25.6K	$304.3K	0.00%	Sep 30, 2025

Izzy EnglanderMar 31, 2026
Millennium Management
Shares
323.6K
Value
$5.9M
% Portfolio
0.00%
Steve CohenMar 31, 2026
Point72 Asset Management
Shares
300K
Value
$5.5M
% Portfolio
0.01%
Ken GriffinSep 30, 2025
Citadel Advisors
Shares
25.6K
Value
$304.3K
% Portfolio
0.00%

Recent activity

Investor	Action	Δ %	Current value	Filing date
Steve Cohen	New	—	$3.6M	Feb 17, 2026
Steve Cohen	New	—	$5.5M	May 15, 2026

Steve Cohen
New
$3.6MFeb 17, 2026
Steve Cohen
New
$5.5MMay 15, 2026

Frequently asked questions

How many institutional investors hold CBIO?: 3 tracked institutional investors disclosed a position in CBIO (CRESCENT BIOPHARMA INC.) in their most recent 13F filing.
Who is the largest institutional holder of CBIO?: Izzy Englander, Millennium Management, holds the largest disclosed position in CBIO, valued at $6M.
Did institutional ownership of CBIO increase or decrease?: Across recent 13F filings, tracked investors recorded 2 new positions, 0 increased, 0 reduced, and 0 fully exited CBIO.
Where does this CBIO ownership data come from?: SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.